Rigel Pharmaceuticals, Inc. (RIGL)
30.68
+0.60
(+1.98%)
USD |
NASDAQ |
Jun 09, 16:00
30.68
0.00 (0.00%)
After-Hours: 19:03
Rigel Pharmaceuticals Total Liabilities (Quarterly) : 104.71M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 117.21B |
| Madrigal Pharmaceuticals, Inc. | 683.87M |
| CytomX Therapeutics, Inc. | 39.41M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 504.61M |
| Shareholders Equity (Quarterly) | 399.90M |
| Debt to Equity Ratio | 0.1143 |
| Current Ratio | 2.615 |
| Net Debt Paydown Yield | 0.57% |